Heinemann L - Search Results

1

Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy.

Barnard KD, Wysocki T, Ully V, Mader JK, Pieber TR, Thabit H, Tauschmann M, Leelarathna L, Hartnell S, Acerini CL, Wilinska ME, Dellweg S, Benesch C, Arnolds S, Holzer M, Kojzar H, Campbell F, Yong J, Pichierri J, Hindmarsh P, Heinemann L, Evans ML, Hovorka R. Barnard KD, et al. Among authors: heinemann l. J Diabetes Sci Technol. 2017 Nov;11(6):1080-1088. doi: 10.1177/1932296817702656. Epub 2017 Apr 3. J Diabetes Sci Technol. 2017. PMID: 28367636 Free PMC article. Clinical Trial.

2

Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients.

Rave K, Heise T, Pfützner A, Heinemann L, Sawicki PT. Rave K, et al. Among authors: heinemann l. Diabetes Care. 2001 May;24(5):886-90. doi: 10.2337/diacare.24.5.886. Diabetes Care. 2001. PMID: 11347749

3

Noninvasive glucose measurement by monitoring of scattering coefficient during oral glucose tolerance tests. Non-Invasive Task Force.

Heinemann L, Krämer U, Klötzer HM, Hein M, Volz D, Hermann M, Heise T, Rave K; Non-Invasive Task Force. Heinemann L, et al. Diabetes Technol Ther. 2000 Summer;2(2):211-20. doi: 10.1089/15209150050025168. Diabetes Technol Ther. 2000. PMID: 11469261

4

Chronic intermittent intravenous insulin therapy: really a new therapeutic option?

Heinemann L. Heinemann L. Diabetes Technol Ther. 2001 Spring;3(1):125-7. doi: 10.1089/152091501750220082. Diabetes Technol Ther. 2001. PMID: 11469702 No abstract available.

5

Variability of insulin absorption and insulin action.

Heinemann L. Heinemann L. Diabetes Technol Ther. 2002;4(5):673-82. doi: 10.1089/152091502320798312. Diabetes Technol Ther. 2002. PMID: 12450450 Review.

6

Continuous glucose monitoring with glucose sensors: calibration and assessment criteria.

Lodwig V, Heinemann L; Glucose Monitoring Study Group. Lodwig V, et al. Among authors: heinemann l. Diabetes Technol Ther. 2003;5(4):572-86. doi: 10.1089/152091503322250596. Diabetes Technol Ther. 2003. PMID: 14511412 Review.

7

Continuous glucose monitoring: reliable measurements for up to 4 days with the SCGM1 system.

Kapitza C, Lodwig V, Obermaier K, Wientjes KJ, Hoogenberg K, Jungheim K, Heinemann L; Glucose Monitoring Study Group. Kapitza C, et al. Among authors: heinemann l. Diabetes Technol Ther. 2003;5(4):609-14. doi: 10.1089/152091503322250622. Diabetes Technol Ther. 2003. PMID: 14511415

8

Impact of particle size and aerosolization time on the metabolic effect of an inhaled insulin aerosol.

Kapitza C, Heise T, Fishman RS, Shapiro DA, Gopalakrishnan V, Rave K, Bott S, Perera AD, Heinemann L. Kapitza C, et al. Among authors: heinemann l. Diabetes Technol Ther. 2004 Apr;6(2):119-27. doi: 10.1089/152091504773731302. Diabetes Technol Ther. 2004. PMID: 15117578 Clinical Trial.

9

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.

Heise T, Nosek L, Rønn BB, Endahl L, Heinemann L, Kapitza C, Draeger E. Heise T, et al. Among authors: heinemann l. Diabetes. 2004 Jun;53(6):1614-20. doi: 10.2337/diabetes.53.6.1614. Diabetes. 2004. PMID: 15161770 Clinical Trial.

10

Measurement of insulin absorption and insulin action.

Heinemann L, Anderson JH Jr. Heinemann L, et al. Diabetes Technol Ther. 2004 Oct;6(5):698-718. doi: 10.1089/dia.2004.6.698. Diabetes Technol Ther. 2004. PMID: 15628821 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

645 results

Search Page

Filters